Search

Search Constraints

You searched for: Author/Creator Adam, Julien

Search Results

1. TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial. Issue 2 (February 2016)

3. Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy. Issue 1 (January 2018)

4. TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer. (2nd December 2018)

5. Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative. (December 2018)

6. Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network. Issue 1 (19th September 2019)

7. Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours. Issue 1 (December 2018)

8. Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma. (December 2018)

9. A comprehensive review on the diagnosis and management of intimal sarcoma of the pulmonary artery. (March 2020)

10. Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAFV600E non–small cell lung cancer. (June 2020)